Formula & Concentration

Antihemophilic Factor (Recombinant), PEGylated Lyophilized Powder for Solution

For Intravenous Injection

Manufacturer

Takeda

Indications

ADYNOVATE, Antihemophilic Factor (Recombinant), PEGylated, is a human antihemophilic factor indicated in adolescent and adult patients (12 years and older) with hemophilia A (congenital factor VIII deficiency) for the on-demand treatment and control of bleeding episodes and for routine prophylaxis to reduce the frequency of bleeding episodes.

ADYNOVATE is not indicated for the treatment of von Willebrand disease.

Product Options

Vial Size

NDC #

200 – 400 IU

00944-4252-02

401 – 800 IU

00944-4254-02

801 – 1250 IU

00944-4256-02

1251 – 2500 IU

00944-4258-02

Shelf Life and Storage

Store Adynovate under refrigeration at a temperature of 36°F-46°F (2°C – 8°C). Adynovate may also be stored at room temperature not to exceed 86°F (30°C) for up to one (1) month.